Several papers describing research into the screening and management of breast cancer patients were presented today at the meeting.
Key Late-Breaking Clinical Trials Covered:
• Prognostic Relevance of Circulating Tumor Cells in the Peripheral Blood of Primary Breast Cancer Patients
• High Independent Prognostic and Predictive Value of Circulating Tumor Cells in a Large Prospective Multicenter Trial Including Serum Tumor Markers in First Line Chemotherapy Metastatic Breast Patients
• Effect of Denosumab Versus Zoledronic Acid Treatment in Patients with Breast Cancer and Bone Metastases: Results from the Extended Blinded Treatment Phase
• Detection of Circulating Tumor Cells Prior to Autologous Stem Cell Transplantation Is Predictive of Shorter Progression Free Survival in Metastatic Breast Cancer
Highlighted in the video is expert commentary from leaders in breast cancer including:
• Brigitte Rack, MD, Head, Department of Gynecological Oncology, Women’s Hospital at the University of Munich
• Jean-Yves Pierga, MD, Professor and Senior Medical Oncologist, Department of Medical Oncology, Institut Curie
• Hui Gao, PhD, Research Scientist, Department of Hematopathology, University of Texas MD Anderson Cancer Center
• Alison T. Stopeck, MD, Associate Professor of Medicine, Cancer Center Division, University of Arizona College of Medicine
For more information from SABCS 2010, please click here: SABCS 2010.